Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ROSE12 + Atezolizumab for Solid Tumor Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial tests a new drug called ROSE12 in patients with advanced or spreading solid tumors. It aims to find a safe dose, understand how the drug works in the body, and see how it interacts with other cancer treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service